Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Richmond, VA
NPI: 1295945764Primary Practice Location
MEDICAL COLLEGE OF VIRGINIA HOSPITALS
1213 E Clay St, Richmond, VA
Primary Employer
MCV Associated Physicians
vcuhealth.org
HQ Phone
Get M.D. Hetal's Phone NumberMobile
Get M.D. Hetal's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
VA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 104 | 168 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 70 | 87 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 59 | 78 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 18 | 18 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 17 | 41 |
Use of Olaparib in the Management of Metastatic Parathyroid Carcinoma With BRCA1 Mutation.
Authors: Woodfield, David, Le, Trang, Prince, Grace, Lee, Hyun, Vachhani, Hetal, Majety, Priyanka
Journal: JCEM Case Rep
Publication Date: 2025-02-17
Authors: Radwan, Rotana M, Schuster, Anne L R, Hertz, Daniel L, Lustberg, Maryam B, Vachhani, Hetal R, Hickey Zacholski, Erin, Sheppard, Vanessa B, Bridges, John F P, Salgado, Teresa M
Journal: Breast Cancer Res Treat
Publication Date: 2025-05-13
Authors: Radwan, Rotana M, Bridges, John F P, Hertz, Daniel L, Lustberg, Maryam B, Vachhani, Hetal, Hickey Zacholski, Erin, Sheppard, Vanessa B, Salgado, Teresa M
Journal: Support Care Cancer
Publication Date: 2025-05-10
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Seagen Inc.
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Placebo Administration, BIOLOGICAL: Trastuzumab Emtansine, DRUG: Tucatinib
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, RADIATION: Radiation Therapy, DRUG: Paclitaxel, BIOLOGICAL: Trastuzumab, DRUG: Nab-paclitaxel, PROCEDURE: Lumpectomy, BIOLOGICAL: Trastuzumab Emtansine, PROCEDURE: Mastectomy, BIOLOGICAL: Pertuzumab
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, PROCEDURE: Biopsy, PROCEDURE: Bone Scan, BIOLOGICAL: Pertuzumab
